Ransomware Intelligence

    Latest Research on INC and The Gentlemen Ransomware: Exposed AI Infrastructure

    Read the Research

    TaslyUS Ransomware Attack

    Ransomware victimRansomed

    alphvGroup
    United StatesCountry
    May 18, 2023Discovered

    About this victim

    Tasly Pharmaceuticals, Inc. (Tasly U.S.) is “Dedicated to a Healthier World.” And our vision is that the world will change the way it takes and understands medicine. Founded in 2006, and following years of research and development, Tasly U.S., based in Rockville, Maryland, is positioned to become a world-renowned innovator in pharmaceuticals, biologics, and nutraceuticals. Among our key accomplishments to date: T89 (Dantonic) has become the first herbal medicine-derived compound to complete an FDA Phase III global trial, yielding promising data. Results indicate that T89’s pharmacological functionalities express clinically significant benefits, including improving blood circulation, boosting energy metabolism level, and reducing blood viscosity. Tasly U.S. believes our initial success with T89 will pave the way for the broader use of herbal medication as an effective and safe alternative to synthesized chemical and biological treatments.

    Industry

    Healthcare

    Country

    United States

    Discovered

    over 3 years ago

    Attack date

    May 18, 2023

    Confidence

    70%

    Severity

    Medium

    Status

    Claimed

    Threat group

    alphv

    Total victims

    0

    Victim's position within group

    Industry

    Healthcare

    Not a listed target sector

    Country

    United States

    Not a listed target country

    Other victims

    Same group (alphv) in this period

    No other victims in the selected period.

    View group profile